Glyphosate Excretion is Associated With Steatohepatitis and Advanced Liver Fibrosis in Patients With Fatty Liver Disease

Paul J Mills; Cyrielle Caussy; Rohit Loomba

doi:10.1016/j.cgh.2019.03.045

Glyphosate Excretion is Associated With Steatohepatitis and Advanced Liver Fibrosis in Patients With Fatty Liver Disease

Clin Gastroenterol Hepatol. 2020 Mar;18(3):741-743. doi: 10.1016/j.cgh.2019.03.045. Epub 2019 Apr 4.

Authors

Paul J Mills¹, Cyrielle Caussy², Rohit Loomba³

Affiliations

¹ Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, California. Electronic address: pmills@ucsd.edu.
² NAFLD Research Center, Department of Medicine, University of California, San Diego, La Jolla, California; Université Lyon 1, Hospices Civils de Lyon, Lyon, France.
³ NAFLD Research Center, Department of Medicine, University of California, San Diego, La Jolla, California; Division of Gastroenterology, Department of Medicine, University of California, San Diego, La Jolla, California.

Abstract

Nonalcoholic fatty liver disease (NAFLD) is currently the most common chronic liver disease in developed countries.¹ Patients with nonalcoholic steatohepatitis (NASH) are considered to be at a higher risk of fibrosis progression and development to cirrhosis and hepatocellular carcinoma.

Publication types

Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Carcinoma, Hepatocellular* / pathology
Disease Progression
Glycine / analogs & derivatives
Glyphosate
Humans
Liver / pathology
Liver Cirrhosis / pathology
Liver Neoplasms* / pathology
Non-alcoholic Fatty Liver Disease* / complications
Non-alcoholic Fatty Liver Disease* / pathology

Substances

Glycine

Abstract

Publication types

MeSH terms

Substances

Grants and funding